Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHCZ0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,504
Award facts
- Contract value 100% obligated
- $16,504.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16.5K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 200-unit vials of BOTOX. The delivery order, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy established to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group's receipt of this delivery order reflects its established performance as a critical pharmaceutical supplier within the federal military medical supply chain. The contractor's broader PPV-G GEN V contract, valued at $499.999 billion with a completion date of December 31, 2036, authorizes DLA to issue firm fixed-price delivery orders for diverse pharmaceutical products including branded and generic prescription drugs, biologics, and medical consumables. The company's extensive product portfolio and demonstrated capability to fulfill specialized pharmaceutical requirements across multiple therapeutic categories position it as a key regional prime vendor contractor supporting DoD healthcare operations globally.
Quick answers
Who was awarded contract SPE2DR26FHCZ0?
SPE2DR26FHCZ0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FHCZ0 worth?
The government has obligated $16,504 on SPE2DR26FHCZ0.
Is contract SPE2DR26FHCZ0 an order under another contract?
Yes. SPE2DR26FHCZ0 is a delivery order under SPE2DR25D9207, an indefinite delivery contract.
Was contract SPE2DR26FHCZ0 competed?
The extent of competition for SPE2DR26FHCZ0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award